Liver

Liver
Gilead challenges GSK with strong HIV drug data

Gilead challenges GSK with strong HIV drug data

Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that works in the same way as the British group's successful dolutegravir. Gilead's bictegravir, another so-called integrase inhibitor drug, delivered 97 percent virus suppression, making it just as effective as GSK's product, data presented at a medical meeting in Seattle late on Monday showed. Importantly, there were no cases of resistance emerging to the new medicine in the 98-patient Phase II study and no patients discontinued treatment due to kidney problems, which can be an issue with HIV treatments.


Liver
Top Tech & Healthcare PR Firms in NYC – An Analysis

Top Tech & Healthcare PR Firms in NYC – An Analysis

By Jon Davis The top tech and healthcare PR firm, Macias PR, has released its 4th quarter report that details the number of media placements the firm secured for its clients from September to December 2016. Macias PR secured a record number of TV placements for its clients in the 4th quarter – a total…
Liver

Finance Monthly Selects Macias PR as the Best PR Firm in the USA

By Luis Gómez Finance Monthly has announced the 2016 winners for the best global firms in public relations, accounting, legal, taxation, banking and finance, asset management and consulting. The magazine named KPMG Taxation Firm of the Year, Macias PR Financial PR Firm of the Year, Deloitte Business Outsourcing Firm of the Year, UBS Wealth Management Investment Firm…